542934 — Chandra Bhagat Pharma Balance Sheet
0.000.00%
- IN₹294.26m
- IN₹411.54m
- IN₹1.16bn
Annual balance sheet for Chandra Bhagat Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | — | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 59 | 65.5 | 51 | 8.02 | 47.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 280 | 212 | 794 | 948 | 762 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 707 | 581 | 979 | 975 | 877 |
| Net Property, Plant And Equipment | 4.73 | 7.28 | 25.2 | 26.2 | 26.2 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 725 | 606 | 1,018 | 1,015 | 942 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 381 | 269 | 711 | 692 | 585 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 458 | 331 | 728 | 716 | 611 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 267 | 275 | 290 | 300 | 331 |
| Total Liabilities & Shareholders' Equity | 725 | 606 | 1,018 | 1,015 | 942 |
| Total Common Shares Outstanding |